Experimental treatment uses modified stem cells to fight cancer
Daniel Apodaca is a 25-year-old film student at UCLA. He's also the first patient in a clinical trial that's testing a treatment using genetically modified bone marrow stem cells to fight cancer......»»
Gilead buys Forty Seven for $4.9 billion to bolster cancer drug pipeline
Gilead Sciences Inc said on Monday it would buy Forty Seven Inc for $4.9 billion in cash, adding an experimental treatment that targets blood cancer to its portfolio of oncology drugs......»»
The most mind-blowing human health discoveries of 2019
Department of Foreign Affairs and Trade/flickr In 2019, science and health experts learned more about the best ways to eat, how immune cells can be programmed to fight cancer, and why vaping might be more dangerous th.....»»
A Big Step Forward in the Fight Against Ovarian Cancer
Aravive shares skyrocketed on Wednesday after the firm announced early-stage data for its ovarian cancer treatment......»»
CAR T-Cells: The New Living Drug for Cancer Treatment Available at the Cancer Center of Kansas
Bassam Mattar, MD, FACP Overview of Cancer Treatments The field of oncology has treated cancer through various forms of chemotherapy and radiation since its beginning. Chemotherapy works by administering drugs to the patient to attack the dividi.....»»
Meet the Newest FDA Approval in the Fight Against Non-Cardia Gastric Cancer
Redhill Bio shares jumped early on Monday after the firm announced that the FDA approved Talicia for the treatment of Helicobacter pylori infection in adults......»»
Duke University trustee awarded Nobel Prize for research that could help fight cancer
A trustee of Duke University has earned the prestigious Nobel Prize for his work on how cells sense oxygen in the body. William Kaelin, one of Duke's newest trustees, has been announced as a recipient of the Nobel Prize for Physiology or Medicine. H.....»»
Frozen assets: How a startup wants to cryobank your cells to fight cancer in the future
The Florida startup has Bay Area investors and is aiming straight at people willing to pay thousands of dollars to beat cancer in the future......»»
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
AstraZeneca Plc will pay up to $6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer, in a direct challenge to the world's biggest cancer drug maker Roche......»»
How do clinical trials help in the fight against cancer?
Clinical trials play a very important role in the treatment of cancer, but they shouldn’t be considered only “when all else fails.†As a patient and physician determine the best course of treatment, clinical trials should be discussed early i.....»»
Biotech"s Soon-Shiong hiring bankers for Nant cancer drug IPO
LOS ANGELES (Reuters) - Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told Reuters......»»
How China Is Evolving From Copycat Medicines Into a Producer of Complex Drugs
Johnson & Johnson was impressed enough by Nanjing Legend Biotechnology’s work on an experimental gene therapy that it paid $350 million for the global rights to the cancer treatment......»»
The Healing Power of Stem Cells
The Healing Power of Stem Cells Your stem cells naturally act as tiny repair mechanisms making them ideal for use in a range of treatment options. We believe in a holistic a.....»»
This cancer-fighting biotech sped from startup to IPO filing in 10 months
The team that took Kite Pharma from a startup re-engineering a patient's own cells to fight cancer to a $12 billion buyout now is seeking a $100 million initial public offering for the South San Francisco company it launched only 10 months ago. Arie B.....»»
Most Surprising Facts About Cancer
The 2018 Nobel Prize for Medicine was recently awarded to Professors James P. Allison and Tasuku Honjo for developing a cancer treatment method that utilizes the body’s immune system to fight........»»
Penn researchers land $10.7M grant to study CAR-T cell therapy in solid tumors
The University of Pennsylvania's Abramson Cancer Center had received a $10.7 million grant from the National Cancer Institute to study CAR-T cells in solid tumors The five-year grant from the NCI's will support new experimental approaches in lung .....»»
This Peninsula biotech foresaw deals worth $3 billion. Now it"s lining up a $57 million merger
OncoMed Pharmaceuticals Inc. — whose wide-ranging deals around cancer stem cells once promised to bring in nearly $3 billion — will merge with a London biotech company for $57.4 million, according to terms of the transaction disclosed Wednesday......»»
The Conversation: How to fight the financial toxicity of cancer treatment
Cancer is one of the most expensive diseases to treat......»»
Wistar’s Zachary Schug and lab are studying the relationship between alcohol intake and some site-specific cancers
What do cancer cells need to thrive and grow? The Wistar Institute’s Dr. Zachary Schug — assistant professor in the Molecular and Cellular Oncogenesis Program at Wistar’s Ellen and Ronald Caplan Cancer Center — studies how cancer cells’ m.....»»
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer......»»
Elias Animal Health seeks $10M for first-of-its-kind treatment, names new exec
Elias Animal Health is preparing to launch its first product, a potentially revolutionary bone cancer treatment for dogs......»»